Motivational deficits and negative symptoms in schizophrenia: Concepts and assessments

Current Topics in Behavioral Neurosciences

Volumn 27, Issue , 2016, Pages 357-373

  Felice Reddy, L ^a   Horan, William P ^a   Green, Michael F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Effort based decision making; Motivation; Negative symptoms; Neurobehavioral; Reward learning; Schizophrenia; Social motivation

Indexed keywords

ANHEDONIA; ANTICIPATORY ANXIETY; ANTISOCIAL BEHAVIOR; ARTICLE; COGNITIVE BEHAVIORAL THERAPY; COGNITIVE DEFECT; COGNITIVE NEUROSCIENCE; COGNITIVE THERAPY; DECISION MAKING; FACIAL EXPRESSION; HALLUCINATION; HUMAN; LEARNING; MOTIVATION; NEGATIVE SYNDROME; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOSOCIAL WITHDRAWAL; RECOGNITION; SCHIZOPHRENIA; ANTICIPATION; PATHOPHYSIOLOGY; PSYCHOLOGY; REWARD;

ANHEDONIA; ANTICIPATION, PSYCHOLOGICAL; DECISION MAKING; HUMANS; MOTIVATION; REWARD; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84975818583     PISSN: 18663370     EISSN: 18663389     Source Type: Book Series    
DOI: 10.1007/7854_2015_379     Document Type: Article

References (82)

1. Aupperle RL, Paulus MP (2010) Neural systems underlying approach and avoidance in anxiety disorders. Dialogues Clin Neurosci 12(4): 517-531.
2. Barch DM, Dowd EC (2010) Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions. Schizophr Bull 36(5): 919-934.
3. Barch DM, Treadway MT et al (2014) Effort, anhedonia, and function in schizophrenia: reduced effort allocation predicts amotivation and functional impairment. J Abnorm Psychol 123 (2): 387-397.
4. Blanchard JJ, Cohen AS (2006) The structure of negative symptoms within schizophrenia: implications for assessment. Schizophr Bull 32: 238-245.
5. Bleuler E (1950) Dementia praecox or the group of schizophrenias. International Universities Press, New York.
6. Curtis CE, Lebow B et al (1999) Acoustic startle reflex in schizophrenia patients and their first-degree relatives: evidence of normal emotional modulation. Psychophysiology 36(4): 469-475.
7. Davis MC, Horan WP et al (2014) Psychopharmacology of the negative symptoms: current status and prospects for progress. Eur Neuropsychopharmacol 24(5): 788-799.
8. Docx L, de la Asuncion J et al (2015) Effort discounting and its association with negative symptoms in schizophrenia. Cogn Neuropsychiatry 20(2): 172-185.
9. Dowd EC, Barch DM (2010) Anhedonia and emotional experience in schizophrenia: neural and behavioral indicators. Biol Psychiatry 67(10): 902-911.
10. Dowd EC, Barch DM (2012) Pavlovian reward prediction and receipt in schizophrenia: relationship to anhedonia. PLoS ONE 7(5): e35622.
11. Eack SM, Mesholam-Gately RI et al (2013) Negative symptom improvement during cognitive rehabilitation: results from a 2-year trial of Cognitive Enhancement Therapy. Psychiatry Res 209(1): 21-26.
12. Favrod J, Giuliani F et al (2010) Anticipatory pleasure skills training: a new intervention to reduce anhedonia in schizophrenia. Perspect Psychiatr Care 46(3): 171-181.
13. Feifel D (2012) Oxytocin as a potential therapeutic target for schizophrenia and other neuropsychiatric conditions. Neuropsychopharmacology 37(1): 304-305.
14. Fervaha G, Graff-Guerrero A et al (2013) Incentive motivation deficits in schizophrenia reflect effort computation impairments during cost-benefit decision-making. J Psychiatr Res 47 (11): 1590-1596.
15. Frank MJ, Claus ED (2006) Anatomy of a decision: striato-orbitofrontal interactions in reinforcement learning, decision making, and reversal. Psychol Rev 113(2): 300-326.
16. Gable SL (2006) Approach and avoidance social motives and goals. J Pers 74(1): 175-222.
17. Gable SL, Gosnell CL (2013) Approach and avoidance behavior in interpersonal relationships. Emot Rev 5(3): 269-274.
18. Gard DE, Kring AM et al (2007) Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure. Schizophr Res 93(1-3): 253-260.
19. Gold JM, Strauss GP et al (2013) Negative symptoms of schizophrenia are associated with abnormal effort-cost computations. Biol Psychiatry 74(2): 130-136.
20. Gold JM, Waltz JA et al (2012) Negative symptoms and the failure to represent the expected reward value of actions: behavioral and computational modeling evidence. Arch Gen Psychiatry 69(2): 129-138.
21. Gold JM, Waltz JA et al (2008) Reward processing in schizophrenia: a deficit in the representation of value. Schizophr Bull 34(5): 835-847.
22. Grant PM, Beck AT (2009) Defeatist beliefs as a mediator of cognitive impairment, negative symptoms, and functioning in schizophrenia. Schizophr Bull 35(4): 798-806.
23. Grant PM, Huh GA et al (2012) Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia. Arch Gen Psychiatry 69(2): 121-127.
24. Gray JA (1987) The psychology of fear and stress. Cambridge University Press, Cambridge.
25. Hartmann MN, Hager OM et al (2014) Apathy but not diminished expression in schizophrenia is associated with discounting of monetary rewards by physical effort. Schizophr Bull 41: 503-512.
26. Heerey EA, Gold JM (2007) Patients with schizophrenia demonstrate dissociation between affective experience and motivated behavior. J Abnorm Psychol 116(2): 268-278.
27. Herbener ES (2009) Impairment in long-term retention of preference conditioning in schizophrenia. Biol Psychiatry 65: 1086-1090.
28. Horan WP, Blanchard JJ (2003) Emotional responses to psychosocial stress in schizophrenia: the role of individual differences in affective traits and coping. Schizophr Res 60(2-3): 271-283.
29. Horan WP, Green MF et al (2006a) Does anhedonia in schizophrenia reflect faulty memory for subjectively experienced emotions? J Abnorm Psychol 115(3): 496-508.
30. Horan WP, Kring AM et al (2006b) Anhedonia in schizophrenia: a review of assessment strategies. Schizophr Bull 32: 259-273.
31. Horan WP, Kring AM et al (2011) Development and psychometric validation of the clinical assessment interview for negative symptoms (CAINS). Schizophr Res 132(2-3): 140-145.
32. Horan WP, Wynn JK et al (2010) Electrophysiological correlates of emotional responding in schizophrenia. J Abnorm Psycholol 119(1): 18-30.
33. Hosking JG, Cocker PJ et al (2014) Dissociable contributions of anterior cingulate cortex and basolateral amygdala on a rodent cost/benefit decision-making task of cognitive effort. Neuropsychopharmacology 39(7): 1558-1567.
34. Johnson DP, Penn DL et al (2011) A pilot study of loving-kindness meditation for the negative symptoms of schizophrenia. Schizophr Res 129(2-3): 137-140.
35. Kane JM (2013) Tools to assess negative symptoms in schizophrenia. J Clin Psychiatry 74(6): e12.
36. Kirkpatrick B, Fenton W et al (2006) The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull 32: 296-303.
37. Kirkpatrick B, Strauss GP et al (2011) The brief negative symptom scale: psychometric properties. Schizophr Bull 37(2): 300-305.
38. Klingberg S, Wolwer W et al (2011) Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical TONES study. Schizophr Bull 37(2): S98-S110.
39. Kraepelin E (1971) Dementia praecox and paraphrenia. Krieger Publishing Co., Inc., Huntington.
40. Kring AM, Barch DM (2014) The motivation and pleasure dimension of negative symptoms: neural substrates and behavioral outputs. Eur Neuropsychopharmacol 24(5): 725-36.
41. Kring AM, Gur RE et al (2013) The clinical assessment interview for negative symptoms (CAINS): final development and validation. Am J Psychiatry 170: 165-172.
42. Kurniawan IT, Seymour B et al (2010) Choosing to make an effort: the role of striatum in signaling physical effort of a chosen action. J Neurophysiol 104(1): 313-321.
43. Kurtz MM, Mueser KT (2008) A meta-analysis of controlled research on social skills training for schizophrenia. J Consult Clin Psychol 76(3): 491-504.
44. Lee B, Groman S et al (2007) Dopamine D2/D3 receptors play a specific role in the reversal of a learned visual discrimination in monkeys. Neuropsychopharmacology 32(10): 2125-2134.
45. Leeson VC, Robbins TW et al (2009) Discrimination learning, reversal, and set-shifting in first-episode schizophrenia: stability over six years and specific associations with medication type and disorganization syndrome. Biol Psychiatry 66(6): 586-593.
46. Marder SR, Alphs L et al (2013) Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia. Schizophr Res 150(2-3): 328-333.
47. Marder SR, Kirkpatrick B (2014) Defining and measuring negative symptoms of schizophrenia in clinical trials. Eur Neuropsychopharmacol 24(5): 737-743.
48. McKirdy J, Sussmann JED et al (2009) Set shifting and reversal learning in patients with bipolar disorder or schizophrenia. Psychol Med 39(08): 1289-1293.
49. Meehl P (1962) Schizotaxia, schizotypy, schizophrenia. Am Psychol 17: 827-838.
50. Milev P, Ho BC et al (2005) Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am J Psychiatry 162(3): 495-506.
51. Modabbernia A, Rezaei F et al (2013) Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia. CNS Drugs 27(1): 57-65.
52. Mueser KT, Sayers SL et al (1994) A multisite investigation of the reliability of the scale for the assessment of negative symptoms. Am J Psychiatry 151(10): 1453-1462.
53. Murray GK, Cheng F et al (2008) Reinforcement and reversal learning in first-episode psychosis. Schizophr Bull 34(5): 848-855.
54. Pantelis C, Barber FZ et al (1999) Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage. Schizophr Res 37(3): 251-270.
55. Pessiglione M, Seymour B et al (2006) Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature 442(7106): 1042-1045.
56. Prentice KJ, Gold JM et al (2008) The Wisconsin Card Sorting impairment in schizophrenia is evident in the first four trials. Schizophr Res 106(1): 81-87.
57. Reddy LF, Green MF et al (2014) Behavioral inhibition and activation systems in schizophrenia: an evaluation of motivational profiles. Schizophr Res 159(1): 164-170.
58. Rummel C, Kissling W et al (2005) Antidepressants as add-on treatment to antipsychotics for people with schizophrenia and pronounced negative symptoms: a systematic review of randomized trials. Schizophr Res 80(1): 85-97.
59. Salamone JD, Correa M (2012) The mysterious motivational functions of mesolimbic dopamine. Neuron 76(3): 470-485.
60. Sayers SL, Curran PJ et al (1996) Factor structure and construct validity of the Scale for the Assessment of Negative Symptoms. Psychol Assess 8: 269-280.
61. Schlagenhauf F, Huys QJM et al (2014) Striatal dysfunction during reversal learning in unmedicated schizophrenia patients. NeuroImage 89: 171-180.
62. Schultz W, Dayan P et al (1997) A neural substrate of prediction and reward. Science 275 (5306): 1593-1599.
63. Siegel SJ, Irani F et al (2006) Prognostic variables at intake and long-term level of function in schizophrenia. Am J Psychiatry 163(3): 433-441.
64. Singh SP, Singh V et al (2010) Efficacy of antidepressants in treating the negative symptoms of chronic schizophrenia: meta-analysis. Br J Psychiatry 197(3): 174-179.
65. Smith KS, Berridge KC (2007) Opioid limbic circuit for reward: interaction between hedonic hotspots of nucleus accumbens and ventral pallidum. J Neurosci 27(7): 1594-1605.
66. Solomon RL (1948) The influence of work on behavior. Psychol Bull 45(1): 1-40.
67. Spielberg JM, Heller W et al (2013) Hierarchical brain networks active in approach and avoidance goal pursuit. Front Hum Neurosci 7(284).
68. Staring ABP, ter Huurne M-AB et al (2013) Cognitive behavioral therapy for negative symptoms (CBT-n) in psychotic disorders: a pilot study. J Behav Ther Exp Psychiatry 44(3): 300-306.
69. Strauss GP, Hong LE et al (2012) Factor structure of the brief negative symptom scale. Schizophr Res 142(1-3): 96-98.
70. Strauss GP, Horan WP et al (2013) Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome. J Psychiatr Res 47(6): 783-790.
71. Strauss GP, Waltz JA et al (2014) A review of reward processing and motivational impairment in schizophrenia. Schizophr Bull 40(Suppl 2): S107-S116. doi: 10. 1093/schbul/sbt197 Epub 2013 Dec 27.
72. Treadway MT, Peterman JS et al (2015) Impaired effort allocation in patients with schizophrenia. Schizophr Res 161(2-3): 382-385.
73. Velthorst E, Koeter M et al (2015) Adapted cognitive-behavioural therapy required for targeting negative symptoms in schizophrenia: meta-analysis and meta-regression. Psychol Med 45 (03): 453-465. doi: 10. 1017/S0033291714001147.
74. Volz M, Hamm AO et al (2003) Temporal course of emotional startle modulation in schizophrenia patients. Int J Psychophysiol 49(2): 123-137.
75. Waltz JA, Gold JM (2007) Probabilistic reversal learning impairments in schizophrenia: further evidence of orbitofrontal dysfunction. Schizophr Res 93(1-3): 296-303.
76. Waltz JA, Kasanova Z et al (2013) The roles of reward, default, and executive control networks in set-shifting impairments in schizophrenia. PLoS ONE 8(2): e57257.
77. Waltz JA, Schweitzer JB et al (2009) Patients with schizophrenia have a reduced neural response to both unpredictable and predictable primary reinforcers. Neuropsychopharmacology 34 (6): 1567-1577.
78. Weiler JA, Bellebaum C et al (2009) Impairment of probabilistic reward-based learning in schizophrenia. Neuropsychology 23(5): 571-580.
79. Wise RA (2004) Dopamine, learning and motivation. Nat Rev Neurosci 5(6): 483-494.
80. Wolf DH, Satterthwaite TD et al (2014) Amotivation in schizophrenia: integrated assessment with behavioral, clinical, and imaging measures. Schizophr Bull 40(6): 1328-1337.
81. Wykes T, Steel C et al (2008) Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr Bull 34(3): 523-537.
82. Wynn JK, Horan WP et al (2010) Impaired anticipatory event-related potentials in schizophrenia. Int J Psychophysiol 77(2): 141-149.